Founded in Culver City, California, NantOmics is a pioneering biotech company dedicated to revolutionizing cancer treatment through precision medicine. As a member of the NantWorks ecosystem, NantOmics leverages advanced molecular testing to detect genomic and proteomic alterations in tumors. Their core mission is to provide personalized treatment options for cancer patients by employing an integrated panomic approach, which combines comprehensive molecular data to tailor therapies specifically to individual patient profiles.
NantOmics has garnered attention through its affiliation with NantWorks, a conglomerate known for innovation in healthcare and technology. The company has achieved significant milestones in the field of molecular diagnostics and personalized medicine, contributing to more effective and individualized cancer treatments. By advancing the capabilities of precision medicine, NantOmics has made a substantial impact on the oncology community, offering hope and improved outcomes for patients worldwide.
